Showing results (7001-7010 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|October 28, 2016
The Effectiveness of Topical Anti-scarring Agents and a Novel Combined Process on Cutaneous Scar ManagementQing-Qing Fang, Chun-Ye Chen, Min-Xia Zhang, et al.Current Pharmaceutical Design|December 31, 2016
Inflammation: A Novel Therapeutic Target/Direction in AtherosclerosisBin Li, Weihong Li, Xiaoli Li, et al.Current Pharmaceutical Design|February 8, 2014
Anesthetic cardioprotection in relation to mitochondria: basic scienceYasushi Mio, Shoichi Uezono, Hiroshi KitahataCurrent Pharmaceutical Design|February 8, 2014
Anesthetic cardioprotection: the role of adenosineStephanie Bonney, Kelly Hughes, Tobias EckleCurrent Pharmaceutical Design|March 20, 2014
Use of trastuzumab for breast cancer: the role of ageWalter Mazzucco, Marta Rossi, Rosanna Cusimano, et al.Current Pharmaceutical Design|March 20, 2014
Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic painAlessandra Del Bufalo, Alfredo Cesario, Gianluca Salinaro, et al.Current Pharmaceutical Design|March 20, 2014
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policiesJean Bousquet, Christian Jorgensen, Michel Dauzat, et al.Current Pharmaceutical Design|May 14, 2008
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathySho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, et al.Current Pharmaceutical Design|May 14, 2008
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's diseaseMasayoshi Takeuchi, Sho-ichi YamagishiCurrent Pharmaceutical Design|May 14, 2008
The role of AGEs in cardiovascular diseaseKarin Jandeleit-Dahm, Mark E CooperPageof 1,009